ethylenediaminetetraacetic acid

also known as EDTA

Investigated by: National Institute of Allergy and Infectious Diseases (NIAID) · Tetraphase Pharmaceuticals, Inc

today NCT03024034 · Ph 1

20172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT03024034	Mar → Dec 2017	bacterial infectious disease	Tetraphase Pharmaceuticals, Inc	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	ethylenediaminetetraacetic acid	“ethylenediaminetetraacetic acid (EDTA)” NCT03024034 ↗
Known as	EDTA	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03024034 ↗